Autres langues Viveve Medical, Inc.

Actions

VIVE

US92852W5013

Marché Fermé - OTC Markets Autres places de cotation 20:20:42 26/04/2024			Varia. 5j.	Varia. 1 janv.
0,0002 ^USD	-33,33 %		-33,33 %	0,00 %

2023	InMode Ltd. (NasdaqGS:INMD) a acquis les actifs de propriété intellectuelle de Viveve Medical Inc.	CI
2023	Mise à jour sectorielle : Les actions du secteur de la santé terminent près des planchers intrajournaliers	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

InMode Ltd. acquired Intellectual Property Assets of Viveve Medical Inc.	25/07/23
Viveve Medical, Inc.(OTCPK:VIVE) dropped from S&P TMI Index	23/01/23
VIVEVE MEDICAL, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	18/01/23
Viveve Medical, Inc.(OTCPK:VIVE) dropped from NASDAQ Composite Index	18/01/23
Sector Update: Health Care Stocks Finishing Near Intra-Day Lows	17/01/23
Sector Update: Health Care Stocks Sputtering in Tuesday Trading	17/01/23
Top Midday Decliners	17/01/23
Sector Update: Health Care	17/01/23
Sector Update: Health Care Stocks Flat to Lower Premarket Tuesday	17/01/23
Sector Update: Health Care	17/01/23
Investors Digest More Big Bank Earnings, Weighing on US Equity Futures	17/01/23
Weak China GDP Data Weigh on Exchange-Traded Funds, Equity Futures Premarket Tuesday	17/01/23
Top Premarket Decliners	17/01/23
Viveve Medical Fails to Meet Primary Endpoint in Stress Urinary Incontinence Study; Unveils Cut in Workforce; Expects Delisting From Nasdaq	17/01/23
Viveve Medical : Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence - Form 8-K	17/01/23
Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence	17/01/23
VIVEVE MEDICAL, INC. : Costs Associated with Exit or Disposal Activities, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits (form 8-K)	17/01/23
Viveve Medical to Seek Strategic Alternatives	17/01/23
VIVEVE MEDICAL, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	15/12/22
Viveve Medical, Inc. Announces Completion of Pivotal US Pursuit Trial for Female Stress Urinary Incontinence	15/12/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Viveve Medical, Inc.

Actions

VIVE

US92852W5013

Autres langues

Filtres